Literature DB >> 28410926

Effect of high density lipoprotein cholesterol on the relationship of serum iron and hemoglobin with kidney function in diabetes.

Ashley N Williams1, Baqiyyah N Conway2.   

Abstract

Findings of increased hemoglobin inside the HDL proteome among persons with diabetes who have haptoglobin 2-2 genotype suggest that iron-induced lipid peroxidation may be involved in diabetic kidney disease. We investigated the relationships of serum hemoglobin and iron with kidney function, and whether this varied by level of HDLc, in 5296 adults with and 49,161 without diabetes. Estimated eGFR was our marker of kidney function. Hemoglobin was positively associated with eGFR among those with diabetes and inversely among those without diabetes (interaction p-value <0.0001). Iron was inversely associated with eGFR regardless of diabetes status. When stratified by median HDLc and median hemoglobin, among persons with diabetes mean eGFR was highest in those with high hemoglobin and low HDLc and lowest in those with both low hemoglobin and low HDLc. This divergent relationship was not observed in the non-diabetic population. In contrast to hemoglobin, high iron and low HDLc were associated with a lower mean eGFR regardless of diabetes status. Our data suggest that among persons with diabetes, both hemoglobin and iron are harmful to kidney function at high levels. Our data also suggest that HDLc may play a role in the relationship of high hemoglobin in kidney function in diabetes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28410926      PMCID: PMC5560583          DOI: 10.1016/j.jdiacomp.2017.03.010

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  38 in total

1.  Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes.

Authors:  Mark E Molitch; Demetra Rupp; Mercedes Carnethon
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

2.  The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.

Authors:  Jarir Atthobari; Auke H Brantsma; Ron T Gansevoort; Sipke T Visser; Folkert W Asselbergs; Wiek H van Gilst; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Nephrol Dial Transplant       Date:  2006-05-23       Impact factor: 5.992

3.  Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.

Authors:  Stephanie J Frisbee; Anoop Shankar; Sarah S Knox; Kyle Steenland; David A Savitz; Tony Fletcher; Alan M Ducatman
Journal:  Arch Pediatr Adolesc Med       Date:  2010-09

4.  Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.

Authors:  S Nielsen; O Schmitz; N Møller; N Pørksen; I C Klausen; K G Alberti; C E Mogensen
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

Review 5.  Intrarenal oxygenation in chronic renal failure.

Authors:  Jill T Norman; Leon G Fine
Journal:  Clin Exp Pharmacol Physiol       Date:  2006-10       Impact factor: 2.557

Review 6.  Renal tubulointerstitial hypoxia: cause and consequence of kidney dysfunction.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-07       Impact factor: 2.557

7.  Lysosomal iron accumulation and tubular damage in rat puromycin nephrosis and ageing.

Authors:  D C Harris; C Tay; B J Nankivell
Journal:  Clin Exp Pharmacol Physiol       Date:  1994-02       Impact factor: 2.557

8.  Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy.

Authors:  Anupama Mohanram; Zhongxin Zhang; Shahnaz Shahinfar; William F Keane; Barry M Brenner; Robert D Toto
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

9.  Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.

Authors:  Rabea Asleh; Shany Blum; Shiri Kalet-Litman; Jonia Alshiek; Rachel Miller-Lotan; Roy Asaf; Wasseem Rock; Michael Aviram; Uzi Milman; Chen Shapira; Zaid Abassi; Andrew P Levy
Journal:  Diabetes       Date:  2008-07-03       Impact factor: 9.461

10.  The C8 health project: design, methods, and participants.

Authors:  Stephanie J Frisbee; A Paul Brooks; Arthur Maher; Patsy Flensborg; Susan Arnold; Tony Fletcher; Kyle Steenland; Anoop Shankar; Sarah S Knox; Cecil Pollard; Joel A Halverson; Verónica M Vieira; Chuanfang Jin; Kevin M Leyden; Alan M Ducatman
Journal:  Environ Health Perspect       Date:  2009-07-13       Impact factor: 9.031

View more
  1 in total

1.  Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.

Authors:  Meijian Guan; Jacob M Keaton; Latchezar Dimitrov; Pamela J Hicks; Jianzhao Xu; Nicholette D Palmer; Lijun Ma; Swapan K Das; Yii-Der I Chen; Josef Coresh; Myriam Fornage; Nora Franceschini; Holly Kramer; Carl D Langefeld; Josyf C Mychaleckyj; Rulan S Parekh; Wendy S Post; Laura J Rasmussen-Torvik; Stephen S Rich; Jerome I Rotter; John R Sedor; Denyse Thornley-Brown; Adrienne Tin; James G Wilson; Barry I Freedman; Donald W Bowden; Maggie C Y Ng
Journal:  Hum Genomics       Date:  2019-05-15       Impact factor: 6.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.